Product NDC: | 45802-822 |
Proprietary Name: | Glimepiride |
Non Proprietary Name: | Glimepiride |
Active Ingredient(s): | 2 mg/1 & nbsp; Glimepiride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 45802-822 |
Labeler Name: | Perrigo New York Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077295 |
Marketing Category: | ANDA |
Start Marketing Date: | 20051006 |
Package NDC: | 45802-822-78 |
Package Description: | 100 TABLET in 1 BOTTLE (45802-822-78) |
NDC Code | 45802-822-78 |
Proprietary Name | Glimepiride |
Package Description | 100 TABLET in 1 BOTTLE (45802-822-78) |
Product NDC | 45802-822 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Glimepiride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20051006 |
Marketing Category Name | ANDA |
Labeler Name | Perrigo New York Inc |
Substance Name | GLIMEPIRIDE |
Strength Number | 2 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Sulfonylurea [EPC],Sulfonylurea Compounds [Chemical/Ingredient] |